Dialysis Patients: Clinical Trials

1 trial for Dialysis Patients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Dialysis Patients: new trials by email Literature Review of Dialysis Patients trials Research Report on Dialysis Patients

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients
Roxadustat, Recombinant human erythropoietin (EPO) - Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD)
Phase 4Not yet recruitingTianjin Medical University General Hospital602025-09-102025-09-09

Narrower conditions

Anemia (1)  ·  Sarcopenia (1)

Broader conditions

Atrophy (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Muscular Atrophy (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

roxadustat (1)

Sponsors

Tianjin Medical University General Hospital (1)

Results publications

PMID 35806119, PMID 36364144, PMID 37812446, PMID 38333911